Allergy & Immunology
News, opinions and meeting coverage in allergy and immunology.
— Agency asks drugmaker for a repeat-dose study before approval
Latest in Allergy & Immunology
Plus: idrevloride for primary ciliary dyskinesia and ultrasound for pulmonary embolism
Most were able to reduce doses without increase in symptoms, exacerbations, trial finds
But biopsy should still remain standard, expert advised
Along with self-monitoring, treatment limited altitude-related adverse health effects vs placebo
But biopsy should still remain standard, expert advised
Along with self-monitoring, treatment limited altitude-related adverse health effects vs placebo
More in Allergy & Immunology
Premenopausal bilateral oophorectomy tied to higher odds of arthritis, sleep apnea, and more
But patients on intervention had better asthma control at study end
Pimecrolimus, tacrolimus, and moderate-potency topical corticosteroids come out on top
But they acknowledge that taking the only shelf-accessible product off the market raises issues
ERS statement suggests action for individual physicians with affected patients
High-opportunity locations tied to lower asthma incidence vs those with low opportunity
New York saw an 82% increase in such visits on the day with the highest recorded pollution
Certain treatment regimens associated with increased risk of fracture
Pozelimab reduced hospitalizations, albumin transfusions in CHAPLE disease patients
PARS performed similarly in patients of different racial and ethnic backgrounds, study reports
Similar incidences of exacerbation, pneumonia hospitalization between inhalers
Also in TTHealthWatch: alpha-gal syndrome and AI for breast cancer screening
Selection praised by infectious disease groups
